Jennison Associates LLC Axonics, Inc. Transaction History

Jennison Associates LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$49.38 - $63.75 $6.34 Million - $8.18 Million	128,374 Added 56.81%	354,331 $22.1 Million
Q3 2023 Oct 31, 2023	BUY	$48.64 - $62.51 $1.2 Million - $1.54 Million	24,631 Added 12.23%	225,957 $12.7 Million
Q1 2023 Apr 26, 2023	BUY	$52.6 - $67.34 $65,381 - $83,703	1,243 Added 0.62%	201,326 $11 Million
Q4 2022 Feb 09, 2023	SELL	$59.56 - $76.6 $7.65 Million - $9.84 Million	-128,460 Reduced 39.1%	200,083 $12.5 Million
Q3 2022 Nov 01, 2022	BUY	$57.96 - $78.12 $381,492 - $514,185	6,582 Added 2.04%	328,543 $23.1 Million
Q2 2022 Aug 02, 2022	SELL	$39.5 - $64.42 $13.9 Million - $22.6 Million	-351,557 Reduced 52.2%	321,961 $18.2 Million
Q1 2022 May 11, 2022	BUY	$43.74 - $62.76 $14.9 Million - $21.4 Million	340,405 Added 102.19%	673,518 $42.2 Million
Q4 2021 Feb 08, 2022	BUY	$50.01 - $73.35 $2.42 Million - $3.54 Million	48,293 Added 16.96%	333,113 $18.7 Million
Q3 2021 Nov 09, 2021	SELL	$59.21 - $78.66 $207,471 - $275,624	-3,504 Reduced 1.22%	284,820 $18.5 Million
Q2 2021 Aug 12, 2021	BUY	$51.39 - $66.9 $14.8 Million - $19.3 Million	288,324 New	288,324 $18.3 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.